این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Public Health، جلد ۵۰، شماره ۱۲، صفحات ۲۵۳۶-۲۵۴۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Protective Effect of Adalimumab on Diabetic Nephropathy by Regulating TNF-α Signal Pathway
چکیده انگلیسی مقاله Background: To evaluate the inhibitory effect of adalimumab on diabetic nephropathyDN) through animal models. Methods: We carried out the study in Weifang People’s Hospital, Weifang 261041, China in December 2020. Streptozotocin was used to induce DN in model animal Sprague-Dawley (SD) rats. The DN animal model was given treatment with adalimumab, and the inhibitory effect of adalimumab on the development process of DN was evaluated by detecting changes in blood glucose and urinary albumin levels. Meanwhile, the content of UN, Cr and CysC of the blood in different experimental groups was tested by weighing the ratio of kidney and performing ELISA to evaluate the protective effect of adalimumab on kidney of DN animal model. In addition, the changes in the transcription and translation levels of tumor necrosis factor α (TNF-α) and its downstream regulatory factors MCP-1 and NF-kB in kidney of different experimental groups were detected by fluorescence quantitative PCR and Western blot tests to further reveal the molecular mechanism of adalimumab inhibiting the diabetic nephropathy. Results: adalimumab could significantly downregulate blood glucose and urinary albumin levels (P < 0.05). The renal body weight ratio and the contents of UN, Cr and Cysc in blood in the adalimumab group were significantly lower than those in the placebo group (P < 0.05). Meanwhile, adalimumab could significantly downregulate the expression of these molecules (P < 0.05). Conclusion: adalimumab could exert its therapeutic effect on diabetic nephropathy through its specific targeting TNF-α signaling pathways.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Zhiying Ding
Emergency Department, Weifang People&#x2019;s Hospital, Weifang 261041, China


| Hongxia Jiang
Department of Endocrinology, The Third People&#x2019;s Hospital of Qingdao, Qingdao 266041, China


| Yongsong Fan
Education Management Department, Affiliated Qingdao Central Hospital, Qingdao University, China


| Guiqin Sun
Department of Endocrinology, The Third People&#x2019;s Hospital of Qingdao, Qingdao 266041, China
نشانی اینترنتی https://ijph.tums.ac.ir/index.php/ijph/article/view/24271
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات